# Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets

> **NCT01179646** · PHASE1 · COMPLETED · sponsor: **Kremers Urban Development Company** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pantoprazole 40 mg DR Tablet vs. Protonix 40 mg DR Tablet

## Key facts

- **NCT ID:** NCT01179646
- **Lead sponsor:** Kremers Urban Development Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2004-06
- **Final completion:** 2004-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2010-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01179646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01179646, "Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01179646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*